Advertisement
Clinical Toxinology Special Section Case Report| Volume 33, ISSUE 4, P412-416, December 2022

Two Cases of Severe Amanita Muscaria Poisoning Including a Fatality

Published:October 06, 2022DOI:https://doi.org/10.1016/j.wem.2022.06.002
      Ingestion of Amanita muscaria mushrooms results in transient central nervous system excitation and depression mediated by its components, ibotenic acid and muscimol. The mushroom is distributed worldwide and ingestions occur with some frequency. Although these ingestions have traditionally been considered benign, serious complications can occur. We present 2 cases of serious toxicity, including a fatality. The first case was a 44-y-old man who presented to the emergency department (ED) after cardiopulmonary arrest approximately 10 h after ingesting 4 to 5 dried A muscaria mushroom caps, which he used for their mind-altering effects. Despite successful resuscitation, he remained unresponsive and hypotensive and died 9 days later. The second case was a 75-y-old man who presented to the ED after accidentally consuming one large A muscaria mushroom cap he foraged in Eastern Turkey. The patient initially presented to the ED with hallucinations followed by lethargy, and he was intubated for airway protection. The patient’s condition gradually improved, and he made a full recovery. A muscaria ingestion should not be considered benign as serious outcomes do occur. An understanding of how the main neuroactive chemicals, ibotenic acid and muscimol, affect the brain can help anticipate outcomes. Several high-risk features that portend a more serious course are identified.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Wilderness & Environmental Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gopinath S.
        • Kumar S.
        • Sasikala M.
        • Ramesh R.
        Mushroom poisoning and its clinical management.
        Int J Pharm Therapeut. 2011; 2: 6-15
        • Crocq M.A.
        Historical and cultural aspects of man's relationship with addictive drugs.
        Dialogues Clin Neurosci. 2007; 9: 355-361
        • Zhang P.
        • Tang L.P.
        • Cai Q.
        • Xu J.P.
        A review on the diversity, phylogeography and population genetics of Amanita mushrooms.
        Mycology. 2015; 6: 86-93
        • Li C.
        • Oberlies N.H.
        The most widely recognized mushroom: chemistry of the genus Amanita.
        Life Sci. 2005; 78: 532-538
        • Gummin D.D.
        • Mowry J.B.
        • Spyker D.A.
        • Brooks D.E.
        • Beuhler M.C.
        • Rivers L.J.
        • et al.
        2018 Annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 36th annual report.
        Clin Toxicol (Phila). 2019; 57: 1220-1413
        • Gummin D.D.
        • Mowry J.B.
        • Spyker D.A.
        • Brooks D.E.
        • Osterthaler K.M.
        • Banner W.
        2017 Annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 35th annual report.
        Clin Toxicol (Phila). 2018; 56: 1213-1415
        • Gummin D.D.
        • Mowry J.B.
        • Spyker D.A.
        • Brooks D.E.
        • Fraser M.O.
        • Banner W.
        2016 Annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 34th annual report.
        Clin Toxicol (Phila). 2017; 55: 1072-1252
        • Mowry J.B.
        • Spyker D.A.
        • Brooks D.E.
        • Zimmerman A.
        • Schauben J.L.
        2015 Annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 33rd annual report.
        Clin Toxicol (Phila). 2016; 54: 924-1109
        • Mowry J.B.
        • Spyker D.A.
        • Brooks D.E.
        • McMillan N.
        • Schauben J.L.
        2014 Annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 32nd annual report.
        Clin Toxicol (Phila). 2015; 53: 962-1147
        • Mowry J.B.
        • Spyker D.A.
        • Cantilena Jr., L.R.
        • McMillan N.
        • Ford M.
        2013 Annual report of the American Association of Poison Control Centers' national poison data system (NPDS): 31st annual report.
        Clin Toxicol (Phila). 2014; 52: 1032-1283
        • Mowry J.B.
        • Spyker D.A.
        • Cantilena Jr., L.R.
        • Bailey J.E.
        • Ford M.
        2012 Annual report of the American Association of Poison Control Centers' national poison data system (NPDS): 30th annual report.
        Clin Toxicol (Phila). 2013; 51: 949-1229
        • Bronstein A.C.
        • Spyker D.A.
        • Cantilena Jr., L.R.
        • Rumack B.H.
        • Dart R.C.
        2011 Annual report of the American Association of Poison Control Centers' national poison data system (NPDS): 29th annual report.
        Clin Toxicol (Phila). 2012; 50: 911-1164
      1. Louisiana State Legislature. Revised Statute. Title 40. Public Health and Safety. RS 40:989.1. Unlawful production, manufacture, distribution, or possession of hallucinogenic plants; exceptions. http://legis.la.gov/Legis/Law.aspx?d=321523. Accessed June 3, 2021.

        • Benjamin D.R.
        Mushroom poisoning in infants and children: the Amanita pantherina/muscaria group.
        J Toxicol Clin Toxicol. 1992; 30: 13-22
        • Mikaszewska-Sokolewicz M.A.
        • Pankowska S.
        • Janiak M.
        • Pruszczyk P.
        • Łazowski T.
        • Jankowski K.
        Coma in the course of severe poisoning after consumption of red fly agaric (Amanita muscaria).
        Acta Biochim Pol. 2016; 63: 181-182
        • Satora L.
        • Pach D.
        • Butryn B.
        • Hydzik P.
        • Balicka-Slusarczyk B.
        Fly agaric (Amanita muscaria) poisoning, case report and review.
        Toxicon. 2005; 45: 941-943
        • Vendramin A.
        • Brvar M.
        Amanita muscaria and Amanita pantherina poisoning: two syndromes.
        Toxicon. 2014; 90: 269-272
        • Moss M.J.
        • Hendrickson R.G.
        Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002–2016.
        ClinToxicol (Phila). 2019; 57: 99-103
        • Stříbrný J.
        • Sokol M.
        • Merová B.
        • Ondra P.
        GC/MS determination of ibotenic acid and muscimol in the urine of patients intoxicated with Amanita pantherina.
        Int J Legal Med. 2012; 126: 519-524
        • Michelot D.
        • Melendez-Howell L.M.
        Amanita muscaria: chemistry, biology, toxicology, and ethnomycology.
        Mycol Res. 2003; 107: 131-146
        • Johnston G.A.
        • Curtis D.R.
        • De Groat W.C.
        • Duggan A.W.
        Central actions of ibotenic acid and muscimol.
        Biochem Pharmacol. 1968; 17: 2488-2489
        • Nielsen E.O.
        • Schousboe A.
        • Hansen S.H.
        • Krogsgaard-Larsen P.
        Excitatory amino acids: studies on the biochemical and chemical stability of ibotenic acid and related compounds.
        J Neurochem. 1985; 45: 725-731
        • Tsujikawa K.
        • Mohri H.
        • Kuwayama K.
        • Miyaguchi H.
        • Iwata Y.
        • Gohda A.
        • et al.
        Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan.
        Forensic Sci Int. 2006; 164: 172-178
        • Buck R.W.
        Toxicity of Amanita muscaria.
        JAMA. 1963; 185: 663-664